Cingulate (CING) Institutional Ownership $3.83 -0.02 (-0.52%) (As of 11/4/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cingulate (NASDAQ:CING)CurrentInstitutional OwnershipPercentage41.31%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$10.86MNumber ofInstitutional Sellers(last 12 months)0 Get CING Insider Trade Alerts Want to know when executives and insiders are buying or selling Cingulate stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CING Institutional Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Cingulate Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC490,000$157K0.0%N/A6.671% 11/15/2023Armistice Capital LLC754,792$535K0.0%N/A4.820% 10/23/2023Commonwealth Equity Services LLC100,771$71K0.0%N/A0.643% 5/5/2023Prime Capital Investment Advisors LLC48,262$48K0.0%N/A0.413% 11/8/2022Eagle Asset Management Inc.107,527$115K0.0%+124.5%0.951% 5/12/2022Eagle Asset Management Inc.47,895$94K0.0%N/A0.424% 5/5/2022Lynwood Capital Management Inc.225,994$445K0.5%+80.8%1.998% 2/14/2022Altium Capital Management LP83,931$232K0.1%N/A0.742% (Data available from 1/1/2016 forward) CING Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CING shares? During the previous two years, the following institutional investors and hedge funds held shares of Cingulate shares: Armistice Capital LLC ($157K), Eagle Asset Management Inc. ($115K), and Commonwealth Equity Services LLC ($71K), Prime Capital Investment Advisors LLC ($48K).Learn more on CING's institutional investors. What percentage of Cingulate stock is owned by institutional investors? 41.31% of Cingulate stock is owned by institutional investors. Learn more on CING's institutional investor holdings. Which institutional investors have been buying Cingulate stock? The following institutional investors have purchased Cingulate stock in the last 24 months: Armistice Capital LLC ($1.24M), Commonwealth Equity Services LLC ($100.77K), Eagle Asset Management Inc. ($59.63K), and Prime Capital Investment Advisors LLC ($48.26K). How much institutional buying is happening at Cingulate? Institutional investors have bought a total of 1,453,457 shares in the last 24 months. This purchase volume represents approximately $14.52M in transactions. Related Companies Trinity Biotech Institutional Ownership Anixa Biosciences Institutional Ownership Rani Therapeutics Institutional Ownership Rockwell Medical Institutional Ownership Eliem Therapeutics Institutional Ownership 23andMe Institutional Ownership PDS Biotechnology Institutional Ownership Werewolf Therapeutics Institutional Ownership Leap Therapeutics Institutional Ownership Immunic Institutional Ownership This page (NASDAQ:CING) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.